Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2003
12/31/2003CN1463727A A TCM compound recipe notoginseng capsule and method for preparing the same
12/31/2003CN1463704A Novel usage of Aspirin-DL-Lysine
12/31/2003CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132607C Yunnan pine nut extract and preparation process and use thereof
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490360A1 Pegylated factor vii glycoforms
12/31/2003CA2490342A1 Stabilised solid compositions of factor vii polypeptides
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2489997A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
12/31/2003CA2489847A1 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
12/31/2003CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2485545A1 (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670455 Use of a chromatography separation processes and/or fractional precipitation
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670387 Thrombocytopenia; hydroxy-1-azo-naphthalene derivatives; 3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo-)-1-naphthalenesul fonic acid; promoters of thrombopoiesis and megakaryocytopoi esis; enhancing platelet production; agonizing TPO receptor
12/30/2003US6670381 Benzamide derivatives as thrombin inhibitors
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003US6670338 Pentasaccharides processes for their preparation and pharmaceutical compositions containing them
12/30/2003US6670323 Hemoglobulin mutations for oxygen delivery
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003CA2140927C Platelet aggregation inhibitors
12/30/2003CA2076063C Sulfated glycosaminoglycanoid derivatives
12/25/2003US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester
12/25/2003US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine
12/25/2003US20030236426 Synthesis of benzimidate from benzoic acid
12/25/2003US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
12/25/2003US20030236267 Benzimidazole derivatives
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines
12/24/2003WO2003106507A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions
12/24/2003WO2003106506A1 Low molecular weight oversulfated polysaccharide
12/24/2003WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
12/24/2003WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
12/24/2003WO2003106403A1 Carboxamides derivatives
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003WO2003105893A2 Probiotic therapies
12/24/2003WO2003105872A1 Anti-spasmodic comprising xenon
12/24/2003WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003WO2003105561A2 Method and devices for diagnosing and treating choroid plexus failure
12/24/2003WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/24/2003WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein
12/24/2003WO2003070182A3 Sodium channel blockers
12/24/2003WO2003068231A3 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
12/24/2003WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
12/24/2003WO2003066806A3 Therapeutic use of aziridino compounds
12/24/2003WO2003061653A9 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
12/24/2003WO2003050251A3 Hematopoietic cells from human embryonic stem cells
12/24/2003WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/24/2003WO2002090542A3 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
12/24/2003WO2002046147A3 Perturbed membrane-binding compounds
12/24/2003CA2489870A1 Low molecular weight oversulfated polysaccharide
12/24/2003CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament
12/24/2003CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/23/2003US6667341 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters; anticancer agents, hemological disorders, and inherited metabolic disorders
12/23/2003US6667332 Benzisoxazolyl-pyrazole derivatives formed by salt formation with maleic acid and hydrochloric acid and cyclization with acetohydroxamic acid
12/23/2003US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates)
12/23/2003US6667313 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/23/2003US6667292 Metabolite is an s-nitroso-low molecular weight thiol compound, s-nitrosoglutathione; blood substitutes and organ perfusion solutions
12/23/2003US6667053 D and L etherlipid stereoisomers and liposomes
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003104412A2 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
12/18/2003WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain
12/18/2003WO2003104260A2 Pharmaceutical formulation
12/18/2003WO2003104250A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
12/18/2003WO2003104230A1 Bicyclic pyrimidine derivatives
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104221A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003103695A1 Novel therapeutic use of polypodium extracts
12/18/2003WO2003103690A1 Antithrombogenic platiniferous ceramic composition and article containing the same
12/18/2003WO2003103687A1 Liquid formulation of decitabine and use of the same
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 671